Clin2
NCT07817069Possibly a fitRecruiting

Nitraria retusa tea for weight issues caused by clozapine

Treatment Resistant SchizophreniaObesity & OverweightAbdominal Obesity

Part of Hormones & metabolism, Mental health clinical trials.

This trial tests whether a tea made from the plant Nitraria retusa can help reduce the weight gain and metabolic side effects caused by the medication clozapine. If you take clozapine for schizophrenia and have gained weight, this tea might help you manage that side effect.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have schizophrenia that has not responded well to other treatments.
  • You are currently taking clozapine (alone or with other medications that do not affect weight much).
  • You have responded well to clozapine (meaning your symptoms improved by at least 20% after 8–12 weeks).
  • You have gained weight or developed central obesity (large waist) after starting clozapine.
  • You are not pregnant or breastfeeding, and you agree to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05170919Enrolling by invitation· Phase 2
Olanzapine vs mirtazapine for weight loss in advanced cancer

This Phase 2 study tests whether the medicines olanzapine or mirtazapine can help people with advanced cancer who are losing weight without trying. It looks at improving unintentional weight loss when standard cancer care is also ongoing.

Englewood, New Jersey
NCT06732245Not yet recruiting· Phase 2
Testing a new drug plus tirzepatide for weight loss

This study tests a new drug, NA-931, combined with an existing weight-loss medication (tirzepatide) to see if they work well and are safe for adults who are overweight or obese. It may help you lose weight and improve health conditions related to excess weight.

Los Angeles, California
NCT06620562Recruiting· Phase 4
Testing a weight loss pill after sleeve gastrectomy surgery

This study tests whether adding a medication (naltrexone/bupropion) to sleeve gastrectomy surgery can improve weight loss. It may be a good fit if you are eligible for a first-time sleeve gastrectomy and meet certain health criteria.

Québec, Quebec
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT05919797Recruiting· Phase 4
Weight loss genetics study with naltrexone and bupropion

This trial studies how your genetic makeup and body response may affect weight loss with a medication combination called naltrexone and bupropion. If you qualify, you’ll likely take these medicines and be monitored for safety and changes in weight over time.

New York, New York

Hear when a new Treatment Resistant Schizophrenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.